13F filer · CIK 1845151
MWG Management Ltd.
Washington, DC · filing since Q4 2020 · last filing Nov 12, 2025
Reported value
$81.3M
+$29.4M vs prior
Positions
3
New / sold out
1 / 1
Added / reduced
0 / 0
Turnover
13.4%
buys $16.4M · sells $8.9M
Top-10 weight
100.0%
Biggest buys vs Q2 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | LYELL IMMUNOPHARMA INC | +1,008,116 | – | +$16.4M |
Biggest sells vs Q2 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | LYELL IMMUNOPHARMA INC | -1,008,116 | -100.0% | $-8.9M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INCCOM | 2,266,934 | $55.0M | 67.66% |
| 2 | LYELL IMMUNOPHARMA INCCOM NEW | 1,008,116 | $16.4M | 20.13% |
| 3 | PRIME MEDICINE INCCOM | 1,792,210 | $9.9M | 12.21% |